Saturday, August 15, 2026

Is China Catching Up? The Impact of AI Model Innovations on U.S.-China Tech Rivalry

China's rapid advancement in AI technology is prompting a new phase in the U.S. strategy to contain China's AI influence.

HM15275 Clinical Trials: What You Need to Know About This Groundbreaking Obesity Treatment

Hanmi Pharmaceutical's HM15275 enters Phase 2 trial, aiming to revolutionize obesity treatment and diabetes management by 2030.

Stray Kids Unveils New Mini Album THIS & THAT: What to Expect from Their Latest Release

Stray Kids avoided direct answers about Grammy nominations, expressing a desire to share heartfelt music with more people.

Tag: Elevar Therapeutics

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Top News

- Our Sponsors Ad -

Follow us